Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for M3 in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $24.06.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in M3. This rating has held steady since October 2022, when it changed from a Hold consensus rating.
M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, Overseas, and Other Emerging Businesses. The Medical Platform segment handles domestic marketing-related services that uses the Internet. It also operates the medical professional site, m3.com. The Evidence Solution segment offers business support for clinical trials. It also manages overall clinical trial operations. The Career Solution segment deals with human resources service business for medical professionals in Japan. The Site Solutions segment covers medical institution management support and home-visit nursing businesses. The Overseas segment provides services such as marketing support, research, clinical trial support, and human resources services for medical companies that use medical professional sites in the United States, United Kingdom, China, South Korea, India, France, Germany, and Spain. The Other Emerging Businesses segment includes consumer services, and medical and welfare national examination preparation services. The company was founded on September 29, 2000 and is h